Cargando…

The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report

BACKGROUND: Major depressive disorder (MDD) patients not responding to two or more different antidepressant treatments are currently considered to suffer from treatment resistant depression (TRD). Recently, intranasal esketamine has been approved by both the American Food and Drug Administration and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matteo, Marcatili, Cristian, Pellicioli, Laura, Maggioni, Federico, Motta, Chiara, Redaelli, Lorenzo, Ghelfi, Michaela, Krivosova, Sibilla, Matteo, Roberto, Nava, Fabrizia, Colmegna, Antonios, Dakanalis, Alice, Caldiroli, Enrico, Capuzzi, Beatrice, Benatti, Francesca, Bertola, Nicoletta, Villa, Alberto, Piperno, Silvia, Ippolito, Massimo, Clerici
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444432/ https://www.ncbi.nlm.nih.gov/pubmed/34530843 http://dx.doi.org/10.1186/s12991-021-00365-z

Ejemplares similares

Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports
por: Marcatili, Matteo, et al.
Publicado: (2022)

Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review
por: Capuzzi, Enrico, et al.
Publicado: (2021)

The psychopathological impact of the SARS-CoV-2 epidemic on subjects suffering from different mental disorders: An observational retrospective study
por: Caldiroli, Alice, et al.
Publicado: (2022)

Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review
por: Caldiroli, Alice, et al.
Publicado: (2021)

P.0638 Comparing the psychological impact of COVID-19 pandemic between psychiatric patients and healthy subjects: an observational retrospective study from northern Italy
por: Turco, M., et al.
Publicado: (2021)

P.0447 The psychopathological impact of the SARS-CoV-2 epidemic on subjects suffering from mental disorders: an observational retrospective study
por: Caldiroli, A., et al.
Publicado: (2021)

Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine’s fast-acting antidepressant mechanisms
por: Marcatili, Matteo, et al.
Publicado: (2020)

Psychiatric emergency care during Coronavirus 2019 (COVID 19) pandemic lockdown: results from a Department of Mental Health and Addiction of northern Italy
por: Capuzzi, Enrico, et al.
Publicado: (2020)

Clinical Markers of Panic and Generalized Anxiety Disorder: Overlapping Symptoms, Different Course and Outcome
por: Caldiroli, Alice, et al.
Publicado: (2023)

Clinical and Peripheral Biomarkers in Female Patients Affected by Anorexia: Does the Neutrophil/Lymphocyte Ratio (NLR) Affect Severity?
por: Caldiroli, Alice, et al.
Publicado: (2023)

The Impact of the COVID-19 Pandemic on Binge Eating Disorder: A Systematic Review
por: Caldiroli, Alice, et al.
Publicado: (2023)

What has the impact of the Coronavirus 2019 (COVID 19) pandemic lockdown been on mental health among young adults?
por: Scalia, A., et al.
Publicado: (2022)

Candidate Biological Markers for Social Anxiety Disorder: A Systematic Review
por: Caldiroli, Alice, et al.
Publicado: (2023)

Clinical and Biological Factors Are Associated with Treatment-Resistant Depression
por: Buoli, Massimiliano, et al.
Publicado: (2022)

Air Pollution and Perinatal Mental Health: A Comprehensive Overview
por: Surace, Teresa, et al.
Publicado: (2023)

Focus on dual diagnosis: a cross-sectional study on risk factors and impact of COVID-19 pandemic in Northern Italy
por: Tagliabue, I., et al.
Publicado: (2022)

Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
por: Biagi, Enrico, et al.
Publicado: (2017)

Association Study of BDNF, SLC6A4, and FTO Genetic Variants with Schizophrenia Spectrum Disorders
por: Bednarova, Aneta, et al.
Publicado: (2023)

High Rate of Discontinuation during Long-Acting Injectable Antipsychotic Treatment in Patients with Psychotic Disorders
por: Auxilia, Anna Maria, et al.
Publicado: (2023)

Sociodemographic and clinical characteristics associated with delirium in hospitalized patients with COVID-19: are immigrants a vulnerable group?
por: Capuzzi, Enrico, et al.
Publicado: (2023)

Delirium in COVID-19 hospitalized patients: sociodemographic and clinical correlates in a small cohort of patients in Northern Italy
por: Cella, F., et al.
Publicado: (2022)

Association of HTTLPR, BDNF, and FTO Genetic Variants with Completed Suicide in Slovakia
por: Bednarova, Aneta, et al.
Publicado: (2023)

Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature
por: Martinotti, Giovanni, et al.
Publicado: (2021)

Biological Predictors of Treatment Response in Adult Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review
por: Capuzzi, Enrico, et al.
Publicado: (2022)

Are There Any Differences in Clinical and Biochemical Variables between Bipolar Patients with or without Lifetime Psychotic Symptoms?
por: Esposito, Cecilia Maria, et al.
Publicado: (2023)

Transformation obsessions in Obsessive-Compulsive Disorder
por: Sharma, Pooja, et al.
Publicado: (2022)

Transformation obsessions in Obsessive-Compulsive Disorder
por: Sharma, Pooja, et al.
Publicado: (2022)

Prevalence of Obsessive-Compulsive Spectrum Disorders in Obsessive-Compulsive Disorder
por: Siddiqui, Mohammad Aleem, et al.
Publicado: (2018)

Heredity in comorbid bipolar disorder and obsessive-compulsive disorder patients
por: AMERIO, Andrea, et al.
Publicado: (2015)

Obsessive–Compulsive Disorder Comorbidity: Clinical Assessment and Therapeutic Implications
por: Pallanti, Stefano, et al.
Publicado: (2011)

Comorbid Bipolar Disorder and Obsessive-Compulsive Disorder: An Old Debate Renewed
por: Amerio, Andrea, et al.
Publicado: (2016)

Clinical and biochemical parameters associated with substance-induced psychotic disorder: which differences between alcohol, cannabis and psychostimulants
por: Nosari, G., et al.
Publicado: (2023)

Perceived Stress in Obsessive–Compulsive Disorder is Related with Obsessive but Not Compulsive Symptoms
por: Morgado, P., et al.
Publicado: (2013)

Epigenetic modulation in obsessive-compulsive disorder: Methylation and hydroxymethylation of the bdnf gene exon I promoter
por: Vanzetto, S., et al.
Publicado: (2021)

Relationship between severity of obsessive-compulsive symptoms and schizotypy in obsessive-compulsive disorder
por: Yamamoto, Haruka, et al.
Publicado: (2012)

Symptom Dimensions in Obsessive-Compulsive Disorder and Obsessive Beliefs
por: Cordeiro, Trinette, et al.
Publicado: (2015)

Psychodynamic Perspective of Sexual Obsessions in Obsessive-Compulsive Disorder
por: Chaudhary, Sonam, et al.
Publicado: (2022)

Clinical management of comorbid bipolar disorder and obsessive-compulsive disorder: A case series
por: Andrea, Amerio, et al.
Publicado: (2018)

Comorbid bipolar disorder and obsessive-compulsive disorder:state of the art in pediatric patients
por: TONNA, Matteo, et al.
Publicado: (2015)

The Effect of Atorvastatin on Obsessive-compulsive Symptoms of Refractory Obsessive-compulsive Disorder (Add-on Therapy)
por: Akouchekian, Shahla, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1sjndrp65b602t7i9f0upvhqjs